Ionis Pharma (IONS) Misses Q3 EPS by 2c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/12/2026

1. MIRM
2. MSFT
3. KTOS
4. PLTR
5. SPY
6. AON
7. TMUS
8. LBRX
9. BMY
10. MRK

Go back to Ionis Pharma (IONS) Misses Q3 EPS by 2c

Ionis Pharmaceuticals Reports Financial Results and Highlights for Third Quarter 2016

November 9, 2016 7:01 AM EST

CARLSBAD, Calif., Nov. 9, 2016 /PRNewswire/ -- Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today reported income from operations of $16.1 million and a loss from operations of $87.5 million for the three and nine months ended September 30, 2016, respectively.  The Company also reported pro forma operating income of $33.7 million and a pro forma net operating loss (NOL) of $30.5 million, both excluding non-cash stock compensation, for the same periods.  Ionis ended the third quarter with cash, cash equivalents and short term investments of $687.8 million.  The Company is on track to meet its pro forma NOL and cash... More